DCB-3503, a tylophorine analog, inhibits protein synthesis through a novel mechanism.

PloS One
Ying WangYung-Chi Cheng

Abstract

DCB-3503, a tylophorine analog, inhibits the growth of PANC-1 (human pancreatic ductal cancer cell line) and HepG2 (human hepatocellular cancer cell line) tumor xenografts in nude mice. The inhibition of growth leads to cancer cell differentiation instead of cell death. However, the mechanisms of action of tylophorine analogs is unknown. In this study, we show that DCB-3503 suppresses the expression of pro-oncogenic or pro-survival proteins with short half-lives, including cyclin D1, survivin, beta-catenin, p53, and p21, without decreasing their mRNA levels. Proteasome inhibitor reversed the inhibitory effect of DCB-3503 on expression of these proteins. DCB-3503 inhibited the incorporation of radiolabeled amino acid and thymidine, and to a much lesser degree of uridine, in a panel of cell lines. The mechanism of inhibition of protein synthesis is different from that of cycloheximide (CHX) as assayed in cell culture and HeLa in vitro translation system. Furthermore, in contrast to rapamycin, DCB-3503 does not affect protein synthesis through the mTOR pathway. DCB-3503 treatment shifts the sedimentation profiles of ribosomes and mRNAs towards the polysomal fractions while diminishing monosome abundance, indicative of the inhibiti...Continue Reading

References

Dec 1, 1992·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·K Adeli, A Theriault
Dec 13, 1991·Science·A MollaE Wimmer
Jan 6, 1992·Biochimica Et Biophysica Acta·R M TujebajevaG G Karpova
May 17, 1991·Cell·Y XiongD Beach
Jul 1, 1983·Biulleten' eksperimental'noĭ biologii i meditsiny·O S MedvedevSh I Ismailov
Jul 27, 1981·Biochimica Et Biophysica Acta·W WillinghamI H Hall
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·C M CrewsS L Schreiber
Nov 21, 1996·Biochemical and Biophysical Research Communications·A MohammadiK Adeli
Dec 1, 1996·International Journal of Hematology·H YamadaJ Horiguchi-Yamada
Jun 11, 1999·Genes & Development·A C GingrasN Sonenberg
Jul 6, 2002·Science·I Bernard Weinstein
Jan 28, 2004·Cancer Research·Wenli GaoYung-Chi Cheng
Feb 11, 2004·Methods in Molecular Biology·Yuri V Svitkin, Nahum Sonenberg
Dec 21, 2004·Genes, Chromosomes & Cancer·Gianpaolo SurianoDavid G Huntsman
May 3, 2005·Bioorganic & Medicinal Chemistry Letters·Zhen XiRunqiu Huang
Jul 22, 2005·Molecular Cancer·Chunjing WuNiramol Savaraj
Aug 16, 2005·Biochemical and Biophysical Research Communications·M NomuraJ Yamashita
May 23, 2006·Molecular Cell·Bingbing WangCarl D Novina
Aug 8, 2006·Journal of Biotechnology·Satoshi MikamiHiroaki Imataka
Sep 30, 2006·Arthritis and Rheumatism·Jin-Young ChoiJoseph Craft
Feb 13, 2007·Free Radical Biology & Medicine·Isabella SaviniLuciana Avigliano
Mar 27, 2007·Cell·Shobha Vasudevan, Joan A Steitz
May 29, 2007·Bioorganic & Medicinal Chemistry Letters·Wenli GaoYung-Chi Cheng
Dec 14, 2007·Bioorganic & Medicinal Chemistry Letters·Wenli GaoYung-Chi Cheng
Oct 9, 2008·Nature Medicine·Gary Ruvkun
May 5, 2009·PloS One·Francis RobertJerry Pelletier
Feb 2, 2010·Nature Chemical Biology·Tilman Schneider-PoetschJun O Liu

❮ Previous
Next ❯

Citations

Sep 16, 2014·ACS Medicinal Chemistry Letters·Ti WenQingmin Wang
Mar 3, 2011·Nature Reviews. Clinical Oncology·Sarah P Blagden, Anne E Willis
Mar 5, 2013·Molecular and Cellular Biochemistry·Juqiang HanQinong Ye

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts
PCR
immunoprecipitation
in vitro transcription
electrophoresis

Software Mentioned

COMPARE

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.